scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1000163081 |
P356 | DOI | 10.1038/IJO.2014.181 |
P8608 | Fatcat ID | release_yiqfsbsxybedzjttjc5r32uzna |
P698 | PubMed publication ID | 25298275 |
P50 | author | Isaac Almendros | Q40289965 |
P2093 | author name string | Y Wang | |
D Gozal | |||
Z Qiao | |||
S X Zhang | |||
A Carreras | |||
E Peris | |||
P2860 | cites work | Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome | Q23761158 |
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span | Q24649811 | ||
Resveratrol improves health and survival of mice on a high-calorie diet | Q27860950 | ||
Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha | Q28274682 | ||
Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway | Q28387166 | ||
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance | Q30009848 | ||
Effects of sleep fragmentation on glucose metabolism in normal subjects | Q33577379 | ||
A macrophage NBR1-MEKK3 complex triggers JNK-mediated adipose tissue inflammation in obesity | Q34143227 | ||
TNF-α and temporal changes in sleep architecture in mice exposed to sleep fragmentation | Q34429593 | ||
Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis | Q34434218 | ||
Chronic sleep fragmentation during the sleep period induces hypothalamic endoplasmic reticulum stress and PTP1b-mediated leptin resistance in male mice | Q34676296 | ||
Sleep fragmentation induces cognitive deficits via nicotinamide adenine dinucleotide phosphate oxidase-dependent pathways in mouse | Q35683048 | ||
DNA methylation in inflammatory genes among children with obstructive sleep apnea | Q35813707 | ||
The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels | Q35918676 | ||
Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes | Q36739771 | ||
Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea | Q36828584 | ||
New pathways to control inflammatory responses in adipose tissue | Q37067301 | ||
Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. | Q37320110 | ||
Epigenetic mechanisms of regulation of Foxp3 expression | Q37412329 | ||
Sleep fragmentation promotes NADPH oxidase 2-mediated adipose tissue inflammation leading to insulin resistance in mice. | Q37534342 | ||
Changes in adipose tissue macrophages and T cells during aging. | Q37617879 | ||
Chronic sleep fragmentation promotes obesity in young adult mice | Q37626898 | ||
Small molecule SIRT1 activators for the treatment of aging and age-related diseases | Q37673310 | ||
Sleep fragmentation in mice induces nicotinamide adenine dinucleotide phosphate oxidase 2-dependent mobilization, proliferation, and differentiation of adipocyte progenitors in visceral white adipose tissue | Q37700389 | ||
Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets | Q38061677 | ||
Exercise- and resveratrol-mediated alterations in adipose tissue metabolism | Q38183160 | ||
Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential | Q38183920 | ||
Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study). | Q40121611 | ||
Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue | Q42707291 | ||
Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes | Q42816602 | ||
Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. | Q43040907 | ||
Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study | Q43299076 | ||
Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis | Q43758043 | ||
Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone | Q46620643 | ||
An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. | Q50562039 | ||
Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice | Q58421056 | ||
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice | Q83637913 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 418-423 | |
P577 | publication date | 2014-10-09 | |
P1433 | published in | International Journal of Obesity | Q6051519 |
P1476 | title | Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea | |
P478 | volume | 39 |
Q38441500 | "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging |
Q57490113 | A Unique Population: Adipose-Resident Regulatory T Cells |
Q35749797 | Acute sleep fragmentation induces tissue-specific changes in cytokine gene expression and increases serum corticosterone concentration |
Q41832970 | Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: Potential role of CD36. |
Q93259206 | Baroreflex Control of Heart Rate in Mice Overexpressing Human SOD1: Functional Changes in Central and Vagal Efferent Components |
Q38759460 | Biological plausibility linking sleep apnoea and metabolic dysfunction |
Q36906844 | Independent Association between Sleep Fragmentation and Dyslipidemia in Patients with Obstructive Sleep Apnea |
Q47662066 | Murine models of sleep apnea: functional implications of altered macrophage polarity and epigenetic modifications in adipose and vascular tissues |
Q89767685 | Obesity, sleep apnea, and cancer |
Q46617003 | Prolonged Exposures to Intermittent Hypoxia Promote Visceral White Adipose Tissue Inflammation in a Murine Model of Severe Sleep Apnea: Effect of Normoxic Recovery |
Q51300509 | Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. |
Q47716193 | Protein-Tyrosine Phosphatase-1B Mediates Sleep Fragmentation-Induced Insulin Resistance and Visceral Adipose Tissue Inflammation in Mice |
Q89983362 | Resveratrol alleviates obesity-induced skeletal muscle inflammation via decreasing M1 macrophage polarization and increasing the regulatory T cell population |
Q47570409 | Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer |
Q64890334 | Sleep-disordered breathing, circulating exosomes, and insulin sensitivity in adipocytes. |
Q47876982 | Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice. |
Q47772610 | Visceral White Adipose Tissue after Chronic Intermittent and Sustained Hypoxia in Mice. |
Search more.